Literature DB >> 19497694

Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT.

Valérie Laurent1, Grégory Trausch, Olivier Bruot, Pierre Olivier, Jacques Felblinger, Denis Régent.   

Abstract

The aim of our study was to compare whole-body MRI (Magnetic Resonance Imaging) with a multi-contrast protocol including a DW (Diffusion Weighted) sequence to PET-CT (Positron Emission Tomography) using (18)FDG (18F-fluoroDeoxyGlucose) for staging advanced melanoma. In a first part, we compared the respective overall accuracy of each modality. We analyzed in a second part the benefits of a DW sequence added to the standard whole-body MRI protocol. Among the population of the 35 patients who experienced the two examinations of our prospective blinded study, we were able to detect 120 lesions and 70 of them were found malignant. The sensitivity and specificity for whole-body MRI were respectively 82% and 97%, while PET-CT reached 72.8% and 92.7%. DW sequence allowed the detection of 14 supplementary malignant lesions (20%) in comparison with standard MRI protocol. Moreover, this technique has been shown to be the most accurate for detecting metastases in the liver, bone, subcutaneous and intra-peritoneal sites. Consequently, a DW sequence should be added systematically to the standard whole-body MRI oncologic protocol because of its high added-value for metastasis detection.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497694     DOI: 10.1016/j.ejrad.2009.04.059

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  30 in total

1.  Optimal b value of diffusion-weighted imaging on a 3.0T magnetic resonance scanner in Crohn's disease.

Authors:  Qi Feng; Yun-Qi Yan; Jiong Zhu; Jin-Lu Tong; Jian-Rong Xu
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].

Authors:  C Pfannenberg; N Schwenzer
Journal:  Radiologe       Date:  2015-02       Impact factor: 0.635

3.  Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?

Authors:  Giuseppe Petralia; Anwar Padhani; Paul Summers; Sarah Alessi; Sara Raimondi; Alessandro Testori; Massimo Bellomi
Journal:  Eur Radiol       Date:  2013-07-25       Impact factor: 5.315

Review 4.  CT, MRI and PET/CT features of abdominal manifestations of cutaneous melanoma: a review of current concepts in the era of tumor-specific therapies.

Authors:  Maxime Barat; Sarah Guegan-Bart; Anne-Ségolène Cottereau; Enora Guillo; Christine Hoeffel; Maximilien Barret; Sébastien Gaujoux; Anthony Dohan; Philippe Soyer
Journal:  Abdom Radiol (NY)       Date:  2020-11-02

Review 5.  Competitive advantage of PET/MRI.

Authors:  Hossein Jadvar; Patrick M Colletti
Journal:  Eur J Radiol       Date:  2013-06-18       Impact factor: 3.528

6.  PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT.

Authors:  Thomas Pfluger; Henriette Ingrid Melzer; Vera Schneider; Christian La Fougere; Eva Coppenrath; Carola Berking; Peter Bartenstein; Mayo Weiss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-06       Impact factor: 9.236

7.  Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.

Authors:  Susann-Cathrin Schüle; Thomas Kurt Eigentler; Claus Garbe; Christian la Fougère; Konstantin Nikolaou; Christina Pfannenberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-18       Impact factor: 9.236

8.  Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors.

Authors:  Maximilien Minon; Clothilde Soriano; David Morland; Thomas Walter; Côme Lepage; Antoine Tabarin; Mathilde Deblock; Pascal Rousset; Coralie Barbe; Christine Hoeffel; Guillaume Cadiot
Journal:  Endocrine       Date:  2019-09-28       Impact factor: 3.633

9.  Diffusion-weighted magnetic resonance imaging without bowel preparation for detection of ulcerative colitis.

Authors:  Li-Li Yu; Hai-Shan Yang; Bu-Tian Zhang; Zhong-Wen Lv; Fu-Rong Wang; Chun-Yu Zhang; Wei-Bo Chen; Hui-Mao Zhang
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

Review 10.  Economic Benefits and Diagnostic Quality of Diffusion-Weighted Magnetic Resonance Imaging for Primary Lung Cancer.

Authors:  Katsuo Usuda; Aika Funazaki; Ryo Maeda; Atsushi Sekimura; Nozomu Motono; Munetaka Matoba; Hidetaka Uramoto
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-10-04       Impact factor: 1.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.